On air · 2 of 3 networks
IQVIA Asia Pacific
- iqvia.com
- Healthcare & Life Sciences
- SG
- 1,473 employees
IQVIA Asia Pacific’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 149. Watch IQVIA Asia Pacific with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 87 | Checked 29 Oct 2026 | See all 149 ads → | ||
| Meta | None recorded | 0 | No active ads recorded on the Meta Ad Library | Checked 22 Oct 2026 | Collect them with the API → |
| Running | 700+ | Ads on the Google Ads Transparency Center | Checked 30 Oct 2026 | Collect them with the API → |
IQVIA Asia Pacific has 87 live LinkedIn ads. Its Facebook page had no active ads on 22 Oct 2026, and we recorded 700+ Google ads on 30 Oct 2026.
Latest ads
- LINKEDIN · VIDEOSince 21 Oct 2026
Dedicated Phase I oncology centres are changing how sponsors approach trial timelines, site selection and execution. In this 3-part video series, Dr Shiraj Sen, Director of Clinical Research at NEXT Oncology, shares his perspective on specialised Phase I oncology centres, consistent execution across site networks, and stronger site-CRO-sponsor collaboration. Explore the full 3-part video series.
- LINKEDIN · VIDEOSince 21 Oct 2026
Following her in-depth sharing at the IQVIA workshop at DIA China 2026, Leanne Magné , Senior Vice President & Head R&D Solutions, Asia-Pacific and Japan, shares key perspectives on navigating today’s clinical development landscape and the considerations shaping trial delivery. If you missed the session, explore the full 3-part video series and catch the key insights.
- LINKEDIN · CAROUSELSince 9 Oct 2026
Clinical trial acceleration isn’t about solving just one challenge. From patient enrolment to trial execution, technology and site partnerships, Leanne Magné , Senior Vice President & Head R&D Solutions, Asia-Pacific and Japan at IQVIA, explores the considerations shaping trial delivery today. Following her in-depth sharing at DIA China, explore her key perspectives in this 3-part video series now.
- LINKEDIN · CAROUSELSince 9 Oct 2026
What is changing the way early phase oncology trials are delivered? From specialized Phase I oncology centres to site networks and closer site-CRO collaboration, new approaches are reshaping early phase trial delivery. Dr Shiraj Sen, Director of Clinical Research at NEXT Oncology, shares his perspectives on what sponsors should consider when planning and executing early phase oncology trials. Explore the full 3-part video series.
- LINKEDIN · VIDEOSince 2 Oct 2026
Dedicated Phase I oncology centres are changing how sponsors approach trial timelines, site selection and execution. In this 3-part video series, Dr Shiraj Sen, Director of Clinical Research at NEXT Oncology, IQVIA, shares his perspective on specialised Phase I oncology centres, consistent execution across site networks, and stronger site-CRO-sponsor collaboration. Explore the full 3-part video series.
- LINKEDIN · CAROUSELSince 28 Sept 2026
What is changing the way early phase oncology trials are delivered? From specialized Phase I oncology centres to site networks and closer site-CRO collaboration, new approaches are reshaping early phase trial delivery. Dr Shiraj Sen, Director of Clinical Research at NEXT Oncology, IQVIA, shares his perspectives on what sponsors should consider when planning and executing early phase oncology trials. Explore the full 3-part video series.
6 of 149 adsSign up to see every IQVIA Asia Pacific ad, filter by format and date, and get alerts on new ones.
See all 149 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.